Search

MK-7145

MK-7145 has been used in trials studying the treatment of Hypertension and Renal Insufficiency.

Ulipristal

The exact mechanism of action for ulipristal is still currently debated, though there is evidence that it functions by inhibiting ovulation.

Hydrochlorothiazide

[A185138,L8447,L8450] Hydrochlorothiazide use is common but declining in favour of angiotensin converting enzyme inhibitors.

Dichlorobenzyl alcohol

[L1113] On the other hand, dichlorobenzyl alcohol is categorized by the FDA in the inactive ingredient for approved drug products.[L2773] … [A33047] Dichlorobenzyl alcohol is considered as an active ingredient found in several marketed OTC products by Health Canada which has categorized this agent as an anatomical therapeutic chemical.

Soy isoflavones

Glycyrrhizic acid

[F80] It was approved by Health Canada to be used in over-the-counter products but all the products are currently on the status canceled post marketed.[L1113] … [A33062] From January 2014, glycyrrhizic acid as part of the licorice extract was approved by the FDA as an existing food sweetener.

Oxilofrine

It is currently marketed in Canada by Valeant under the tradename Cophylac.

Pancrelipase amylase

[L2509] The amylases are enzymes that help in the chemical process of digestion by hydrolizing starch into more available saccharide forms. … [L2512] The pancrelipase mixture, including pancrelipase amylase, was developed by Ortho-McNeil-Janssen Pharmaceuticals, Inc and FDA approved on April 12, 2010.[L2510]

Quinupristin

Quinupristin/dalfopristin is a combination of two antibiotics used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium.

Seproxetine

Seproxetine was being investigated by Eli Lilly as an antidepressant but development was never completed and the drug was never marketed.